118 related articles for article (PubMed ID: 2320949)
1. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
Holtmann G; Küppers U; Singer MV
Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
[TBL] [Abstract][Full Text] [Related]
2. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
Coruzzi G; Adami M; Bertaccini G
Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
[TBL] [Abstract][Full Text] [Related]
3. Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding.
Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Kromer W
Digestion; 1989; 44(2):66-78. PubMed ID: 2575551
[TBL] [Abstract][Full Text] [Related]
4. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
Singer MV; Teyssen S; Küppers U
Digestion; 1991; 48(1):34-42. PubMed ID: 1868967
[TBL] [Abstract][Full Text] [Related]
5. Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.
Londong W; Londong V; Meierl A; Voderholzer U
Gut; 1987 Jul; 28(7):888-95. PubMed ID: 3653758
[TBL] [Abstract][Full Text] [Related]
6. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
Hirschowitz BI; Fong J; Molina E
J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs.
Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV
Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic influence on pentagastrin and bethanechol stimulated gastric acid secretion in dogs with gastric fistula.
Hovendal C; Bech K; Gottrup F; Andersen D
Scand J Gastroenterol Suppl; 1984; 89():19-22. PubMed ID: 6146191
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
de Ponti F; Einaudi A; Cosentino M; D'Angelo L; Lecchini S; Frigo GM; Crema A
J Pharmacol Exp Ther; 1993 Feb; 264(2):789-94. PubMed ID: 8437127
[TBL] [Abstract][Full Text] [Related]
11. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
[TBL] [Abstract][Full Text] [Related]
12. An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Kromer W; Gönne S
Pharmacology; 1988; 37 Suppl 1():48-53. PubMed ID: 3237766
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide: potent peripheral inhibitor of gastric acid secretion in rats and dogs.
Taché Y; Pappas T; Lauffenburger M; Goto Y; Walsh JH; Debas H
Gastroenterology; 1984 Aug; 87(2):344-9. PubMed ID: 6145652
[TBL] [Abstract][Full Text] [Related]
14. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy.
Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1550-9. PubMed ID: 9227493
[TBL] [Abstract][Full Text] [Related]
15. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.
Galvan M; Boer R; Schudt C
Eur J Pharmacol; 1989 Aug; 167(1):1-10. PubMed ID: 2776837
[TBL] [Abstract][Full Text] [Related]
16. Use of impromidine to define specific histamine H-2 effects on gastric secretion, heart rate and blood pressure in conscious dogs.
Molina E; Rentz J; Hirschowitz BI
J Pharmacol Exp Ther; 1980 Sep; 214(3):483-7. PubMed ID: 6447202
[TBL] [Abstract][Full Text] [Related]
17. A new diagnostic test for incomplete vagotomy: experimental study in dogs.
Niv Y; Chamud M; Mysh V
Isr J Med Sci; 1993 Nov; 29(11):688-91. PubMed ID: 8270397
[TBL] [Abstract][Full Text] [Related]
18. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric acid secretion in rats and in dogs by corticotropin-releasing factor.
Taché Y; Goto Y; Gunion M; Rivier J; Debas H
Gastroenterology; 1984 Feb; 86(2):281-6. PubMed ID: 6606593
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on pentagastrin-stimulated gastric acid secretion and gastric antral motility in dogs with gastric fistula.
Bech K; Andersen D
Scand J Gastroenterol; 1984 Sep; 19(6):740-6. PubMed ID: 6151241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
